Receiving a cancer diagnosis can be a traumatic and lonely experience. Learn how to support a loved one's cancer journey and ...

The negative impact of obesity on prognosis was especially pronounced in patients with acute lymphoblastic leukemia and brain ...

This Genomic Biomarkers market report covers market characteristics, size and growth, segmentation, regional and country ...

My prayer and mission is to help women of all ages know what to look for with Ovarian Cancer and encourage them to go to the ...

Women suffering from PCOD are confronted with unique problems during IVF, ranging from ovarian hyperstimulation to issues of ...

MILWAUKEE, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The Dr. Scott Kamelle Award for Ovarian Cancer Survivors is a prestigious initiative aimed at celebrating the resilience, strength, and personal ...

Shares of Verastem Oncology VSTM rallied 40.9% on Tuesday after it announced that the FDA has accepted the new drug application (NDA) for its avutometinib/defactinib ...

The firm e expects FDA approval for the combination by mid-2025, marking the first FDA approved treatment option for women with KRAS mutant low-grade serous ovarian cancer. With FDA acceptance of ...

Kristen Fischer has written for numerous health publications, hospitals, and medical companies, and is a member of the Association of Health Care Journalists. Women with severe endometriosis have ...

CD4/CD6 are a class of medications that can be used to treat certain types of hormone receptor-positive breast cancer. Estrogen receptor-positive means a breast cancer needs the hormone estrogen to ...

Known for its painful symptoms and complications, such as difficulty in conceiving, it is also linked with concerns about an increased risk of ovarian cancer. While the risk is relatively low, studies ...